 | Up a level |
Journal Article
Hyman, David Michael, Jaime, Jesus Corral, Garralda, Elena, Machiels, Jean-Pascal H., Schellens, Jan H. M., Bedard, Phillipe, Campone, Mario, Cassier, Philippe, Sarantopoulos, John, Vaishampayan, Ulka N., Chugh, Rashmi 
ORCID: 0000-0002-4633-6971, Mahipal, Amit, Lockhart, Albert C., Sessa, Cristiana, Zander, Thomas, Ng, Matthew, Curigliano, Giuseppe ORCID: 0000-0003-1781-2518, Bendiske, Jennifer and Perez-Garcia, Jose Manuel
(2016).
Phase Ib study of BGJ398 in combination with BYL719 in patients (pts) with select advanced solid tumors.
J. Clin. Oncol., 34 (15).
ALEXANDRIA:
AMER SOC CLINICAL ONCOLOGY.
ISSN 1527-7755
Joerger, Markus, Cassier, Philippe, Penel, Nicolas, Cathomas, Richard, Richly, Heike, Schostak, Martin, Janitzky, Andreas, Wermke, Martin, Nogova, Lucia, Tai, David Wai-Meng, Sayehli, Cyrus, Gruellich, Carsten, Grande, Enrique, Navarro, Alejandra, Park, Se Hoon, Gillessen, Silke, Nogai, Hendrik, Bender, Sebastian, Ellinghaus, Peter and Schuler, Martin H. (2018). Rogaratinib treatment of patients with advanced urothelial carcinomas prescreened for tumor FGFR mRNA expression. J. Clin. Oncol., 36 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755
Kempf, Emmanuelle, Penel, Nicolas, Tournigand, Christophe, Gajate, Pablo, Tan, Daniel Shao-Weng, Cassier, Philippe, Nogova, Lucia, Cathomas, Richard, Schostak, Martin, Janitzky, Andreas, Wermke, Martin, Sayehli, Cyrus, Navarro, Alejandro, Park, Se Hoon, Piciu, Ana-Maria, Bender, Sebastian, Nogai, Hendrik, Ellinghaus, Peter, Joerger, Markus and Schuler, Martin H. (2020). Phase I experience with rogaratinib in patients (pts) with urothelial carcinoma (UC) selected based on FGFR mRNA overexpression. J. Clin. Oncol., 38 (6). ALEXANDRIA: AMER SOC CLINICAL ONCOLOGY. ISSN 1527-7755